A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B

Figure 4

Decision curves for prediction of the net benefit of the constructed nomogram, FIB-4, and APRI. Solid gray line: a perfect prediction model; horizontal solid black line: screen none; red line: screen based on the nomogram; green line: screen based on the FIB-4; blue line: screen based on the APRI. (a) The net benefit of screen patients in the training set according to the nomogram, FIB-4, and APRI. (b) The net benefit of screen patients in the validation set according to the nomogram, FIB-4, and APRI.

(a)

(b)